| Literature DB >> 35260163 |
Yu-Shan Wu1, Chiehfeng Chen2,3, Lin-Chien Wang1, Li-Shan Jian4, Yu Ko5,6.
Abstract
BACKGROUND: Health technology assessment (HTA) has become essential in many countries over the past few years, and the demand for HTA professionals has increased in academia, governments, and industries. This study aimed to examine which courses are most important and which training activities are most helpful for the development of HTA proficiency as perceived by HTA experts.Entities:
Keywords: Expert survey; Health technology assessment; Questionnaire
Mesh:
Year: 2022 PMID: 35260163 PMCID: PMC8903637 DOI: 10.1186/s12909-022-03214-z
Source DB: PubMed Journal: BMC Med Educ ISSN: 1472-6920 Impact factor: 2.463
Respondent characteristics
| Variables | Mean(SD) |
|---|---|
| Age (years) | 43.2 (11.0) |
| Working in HTA-related fields (years) | 11.3 (9.9) |
| No. (%) | |
| Gender | |
| Female | 39 (57.4%) |
| Male | 13 (42.6%) |
| Education | |
| College | 3 (4.4%) |
| Masters and equivalent | 28 (41.2%) |
| PhD and equivalent | 37 (54.4%) |
| Specialized Fields | |
| Industry | 15 (22.1%) |
| Government | 23 (33.8%) |
| Academia | 30 (44.1%) |
| Country | |
| Taiwan | 40 (58.8%) |
| Others | 28 (41.2%) |
The assessments of the importance of HTA courses
| Pharmacoeconomics & outcomes research / Cost-effectiveness analysis / Pharmacy administration & pharmacoeconomics | 4.80 | 0.41 | 84 | 64 | 46 |
| Health economics | 4.68 | 0.68 | 71 | 39 | 31 |
| Epidemiology | 4.50 | 0.74 | 50 | 45 | 30 |
| Health outcome research | 4.47 | 1.00 | 37 | 18 | 19 |
| Biostatistics | 4.44 | 0.67 | 56 | 33 | 6 |
| Evidence-based medicine / Application of clinical evidence-based medicine | 4.41 | 0.70 | 42 | 42 | 13 |
| Economic evaluation of health care policy | 4.34 | 0.70 | 32 | 35 | 44 |
| Clinical evidence-based drug evaluation | 4.26 | 0.80 | 7 | 23 | 9 |
| Patient-reported outcomes measurement / Health indicators & measurement | 4.21 | 0.87 | 16 | 4 | 7 |
| Clinical trials | 4.00 | 0.69 | 12 | 15 | 3 |
| Academic writing | 3.71 | 0.90 | 6 | 8 | 2 |
| Drug information | 3.69 | 0.87 | 7 | 2 | 3 |
| Application of statistical software | 3.63 | 0.96 | 8 | 3 | 0 |
| Pharmacy administration & law / Regulations of medicinal product registration | 3.43 | 0.90 | 4 | 4 | 3 |
| Concept of management | 3.00 | 0.99 | 2 | 0 | 4 |
| Public relations & mass communication | 2.91 | 0.99 | 0 | 1 | 5 |
Difficulties encountered by respondents in conducting HTA
| Difficulties encountered | All respondents ( | Domestic respondents ( | Overseas respondents ( | Academia ( | Government ( | Industry ( |
|---|---|---|---|---|---|---|
| Lack of local data | 36 (52.9%) | 21 (52.5%) | 15 (53.6%) | 15 (50.0%) | 18 (78.3%) | 3 (20.0%) |
| Recruitment is not easy | 32 (47.1%) | 17 (42.5%) | 15 (53.6%) | 16 (53.3%) | 11 (47.8%) | 5 (33.3%) |
| Government values budget impact analysis more than cost-effectiveness analysis | 31 (45.6%) | 22 (55.0%) | 9 (32.1%) | 11 (36.7%) | 9 (39.1%) | 11 (73.3%) |
| Difficulties in connecting theories with practices | 23 (33.8%) | 18 (45.0%) | 5 (17.9%) | 10 (33.3%) | 7 (30.4%) | 6 (40.0%) |
| HTA research is not valued | 20 (29.4%) | 16 (40.0%) | 4 (14.3%) | 8 (26.7%) | 6 (26.1%) | 6 (40.0%) |
| The views among industry, academia and government are significantly different | 20 (29.4%) | 13 (32.5%) | 7 (25.0%) | 7 (23.3%) | 8 (34.8%) | 5 (33.3%) |
| Technical difficulties at the implementation level | 17 (25.0%) | 9 (22.5%) | 8 (28.6%) | 7 (23.3%) | 6 (26.1%) | 4 (26.7%) |
| Existing personnel transformation (e.g., transfer from other areas to HTA) is difficult | 14 (20.6%) | 8 (20.0%) | 6 (21.4%) | 5 (16.7%) | 6 (26.1%) | 3 (20.0%) |
| The cost of training new recruits is too high | 12 (17.6%) | 6 (15.0%) | 6 (21.4%) | 5 (16.7%) | 6 (26.1%) | 1 (6.7%) |
| Other | 8 (11.8%) | 2 (5.0%) | 6 (21.4%) | 3 (10.0%) | 5 (21.7%) | 0 (0.0%) |